
BAJAJHCARE
NSEPrice History
Investment Checklist
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Trend
Mixed MA signals — sideways/transition | Bearish MA stack (20<50<200)
Price Action
Support & Resistance Levels
Volume Analysis
Recent MA Crossovers
Stop Loss Levels
Fixed Risk
Technical Levels
Moving Averages
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹122.8 Cr | ₹154.5 Cr | ₹148.8 Cr | ₹161.2 Cr |
| Net Profit | ₹11.7 Cr | ₹11.2 Cr | ₹11.8 Cr | ₹15.7 Cr |
| EPS | ₹3.65 | — | ₹3.74 | ₹4.96 |
| Operating Profit | ₹24 Cr | ₹25.3 Cr | ₹25.4 Cr | ₹32.3 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 19 Sept 2025 | Dividend - Re 1 Per Share | DIVIDEND |
| 23 Sept 2024 | Annual General Meeting/Dividend - Re 1 Per Share | AGM |
| 22 Sept 2023 | Annual General Meeting/Dividend - Re 1 Per Share | AGM |
| 22 Sept 2022 | Annual General Meeting/Dividend - Rs 1.50 Per Share | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for BAJAJHCARE
View All
At 100, the Bajaj Group is writing a new chapter—on healthcare
After 100 years of saying no to diversification, one of India’s fastest-growing wealth engines is finally scratching its ultimate itch. Powered by a ₹5,800-crore dividend chest, the billionaire cousins from the Bajaj Group have said ‘yes’ to one sector: healthcare.
Bajaj Group to enter healthcare biz with Rs 2k cr bet in Pune; expand to 7 cities in a decade
The Bajaj group is entering the healthcare sector. A significant investment of over Rs 2,000 crore is planned for Pune over the next three years. The group aims to establish a comprehensive healthcare model. This initiative will expand to multiple cities in the coming decade. The focus is on providing care from prevention to acute intervention.
Bajaj Healthcare reports dismal Q4 PAT
Bajaj Healthcare reported a standalone net loss of Rs 22.85 crore in Q4 FY26, compared with a net profit of Rs 11.17 crore posted in Q4 FY25.